Biotechnology giant Amgen has agreed to acquire BioVex Group, a privately held biotechnology company that is developing OncoVex, a novel oncolytic vaccine to treat head
A study conducted in four American Indian communities in the Pacific Northwest shows that eliminating sugary drinks from the diets of the youngest members of
SAN FRANCISCO – While commercially available optical tools can help clinicians identify premalignant lesions in the oral cavity, the prevalence of confounding lesions increases the
With more than 1.4 million new cases of cancer diagnosed each year in the U.S. and more of these patients undergoing outpatient treatment, dental practitioners
HIV-positive head and neck cancer patients respond well to radiation therapy treatments and experience toxicity rates similar to HIV-negative patients, according to a study in
Acacia Pharma has initiated a phase I clinical study of APD515, an oromucosal formulation of an existing drug, for use in the treatment of xerostomia
A Saudi Arabian court dismissed a lawsuit filed by a man with throat cancer against a tobacco company because there was no clear-cut evidence that
Patients with pharyngeal cancer had better salivary function, less xerostomia, and improved quality of life when treated with parotid-sparing intensity-modulated radiotherapy (IMRT) rather than conventional
In his first TV interview since undergoing treatment for stage IV oropharyngeal cancer, actor Michael Douglas said his tumor is gone and that he may
There are predators in the bacterial world that consume other bacteria, much as predators attack prey in the animal world. A team led by researchers
A new robotic surgical procedure offers patients with oral and head and neck cancers a less invasive treatment option that preserves speech and the ability
Henry Schein Dental is now the exclusive distributor of LED Dental’s new VELscope Vx Enhanced Oral Assessment system in North America, the companies announced. The